KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in IntangiblesChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Pacific Biosciences Of California (PACB) Change in Account Payables (2016 - 2025)

Historic Change in Account Payables for Pacific Biosciences Of California (PACB) over the last 17 years, with Q3 2025 value amounting to $1.3 million.

  • Pacific Biosciences Of California's Change in Account Payables rose 12255.88% to $1.3 million in Q3 2025 from the same period last year, while for Sep 2025 it was $4.4 million, marking a year-over-year increase of 21789.36%. This contributed to the annual value of $1.4 million for FY2024, which is 58203.88% up from last year.
  • According to the latest figures from Q3 2025, Pacific Biosciences Of California's Change in Account Payables is $1.3 million, which was up 12255.88% from $1.0 million recorded in Q2 2025.
  • In the past 5 years, Pacific Biosciences Of California's Change in Account Payables ranged from a high of $6.6 million in Q1 2024 and a low of -$5.6 million during Q3 2024
  • Its 5-year average for Change in Account Payables is $513684.2, with a median of $153000.0 in 2021.
  • In the last 5 years, Pacific Biosciences Of California's Change in Account Payables soared by 406535.95% in 2022 and then plummeted by 152000.0% in 2023.
  • Pacific Biosciences Of California's Change in Account Payables (Quarter) stood at $6.2 million in 2021, then plummeted by 107.88% to -$486000.0 in 2022, then plummeted by 208.64% to -$1.5 million in 2023, then skyrocketed by 341.8% to $3.6 million in 2024, then crashed by 65.1% to $1.3 million in 2025.
  • Its last three reported values are $1.3 million in Q3 2025, $1.0 million for Q2 2025, and -$1.5 million during Q1 2025.